FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096105 [Registered on: 15/10/2025] Trial Registered Prospectively
Last Modified On: 14/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Brain and nerve stimulation for depression in cancer patients receiving radiation. 
Scientific Title of Study   Comparing the effect of Transcranial direct current stimulation versus Transauricular vagus nerve stimulation on depressive symptoms in cancer patients undergoing radiation therapy- A Randomised Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Gayatri Govindankutty Marar 
Designation  Post graduate Student 
Affiliation  KLE Institute of Higher Education and Research Center 
Address  KLEs Dr. Prabhakar Kore Hospital and Medical Research Center, Sagar Floor, Advanced physiotherapy center, Department of Neurology physiotherapy, Belgaum

Belgaum
KARNATAKA
590010
India 
Phone  07902341557  
Fax    
Email  gayatrimarar23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Gayatri Govindankutty Marar 
Designation  PG Student 
Affiliation  KLE Institute of Physiotherapy 
Address  KLEs Dr. Prabhakar Kore Hospital and Medical Research Center, Sagar Floor, Advanced physiotherapy center, Department of Neurology physiotherapy, Belgaum, Karnataka

Belgaum
KARNATAKA
590010
India 
Phone  07902341557  
Fax    
Email  gayatrimarar23@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Raghavendrasingh Dharwadkar 
Designation  Assistant professor 
Affiliation  KLE Institute of Physiotherapy 
Address  KLEs Dr. Prabhakar Kore Hospital and Medical Research Center, Room no. 39, Sagar Floor, Advanced physiotherapy center, Department of Neurophysiotherapy, Belgaum, Karnataka B

Belgaum
KARNATAKA
590010
India 
Phone  07902341557  
Fax    
Email  raghavendrasingh@klekipt.edu.in  
 
Source of Monetary or Material Support  
KLEs Dr. Prabhakar kore Hospital and Medical Research center, Department of neurology physiotherapy, Belgaum, Karnataka, India, 590010 
 
Primary Sponsor  
Name  Gayatri Govindankutty Marar 
Address  KLEs Dr. Prabhakar Kore Hospital and Medical Research Center, Room no. 39, Sagar Floor, Advanced physiotherapy center, Department of Neurology physiotherapy, Belgaum, Karnataka, 590010 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Gayatri Govindankutty Marar  KLEs Dr. Prabhakar kore Hospital and Medical Research center, Belagavi, Karnataka 590010  KLEs Dr. Prabhakar Kore Hospital and Medical Research Center, Room no. 39, Sagar Floor, Advanced physiotherapy center, Department of Neurophysiotherapy, Belgaum, Karnataka
Belgaum
KARNATAKA 
07902341557

gayatrimarar23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research and ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C801||Malignant (primary) neoplasm, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  taVNS + Conventional physiotherapy  Training frequency- 5 sessions per week Training duration- 30 minutes Number of weeks- 2 weeks Exercises- 30 minutes per session 
Intervention  tDCS + Conventional physiotherapy  Training frequency- 5 sessions per week Training duration- 30 minutes Number of weeks- 2 weeks Exercises- 30 minutes per session 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1.Participant diagnosed with cancer who are in the age group of 40 to 80 years of both genders.
2.Participants willing to participate.
3. Participants with beck depression inventory more than 13.
 
 
ExclusionCriteria 
Details  1.Participants having any metal implants.
2.Participants who are undergoing any forms of psychotherapy.
3.Participants having history of uncontrolled epilepsy.
4.Participants having pacemaker.
5.Participants with acute ear infections.
6.Participants with cardiovascular risk or unstable cardiac disease.
7.Participants with unstable medical conditions.
8.Participants with active skin disease at electrode sites 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Centralized 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
PHQ-9 scale is used to assess the depression and is assessed post intervention  baseline and at 2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
fatigue severity scale is used to assess fatigue level of the patient  baseline & at 2 weeks 
EORTC QOL-C30 scale is used to assess the quality of life  baseline & at 2 weeks 
 
Target Sample Size   Total Sample Size="22"
Sample Size from India="22" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study focuses on addressing the high prevalence of depression in cancer patients receiving radiotherapy, which negatively affects their quality of life, treatment adherence, and outcomes. Since pharmacological options may add side effects in patients already on multiple medications, this study explores two non-invasive neuromodulation techniques—tDCS and taVNS—as safer alternatives. Using a randomized clinical trial design with 22 participants, patients will be assigned to receive either tDCS or taVNS along with conventional physiotherapy for two weeks, and outcomes will be assessed using PHQ-9, Fatigue severity scale, and EORTC QLQ-C30 scales. The aim is to compare the effectiveness of tDCS and taVNS in reducing depressive symptoms, fatigue, and improving quality of life in this patient group. 
Close